Paroxysmal hemicrania and POEMS syndrome: further evidence that neuropeptides are implicated in primary headache?

Cephalalgia. 2008 Nov;28(11):1204-6. doi: 10.1111/j.1468-2982.2008.01669.x. Epub 2008 Jul 15.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Angiogenesis Inhibitors / therapeutic use
  • Anti-Inflammatory Agents / therapeutic use
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
  • Antibodies, Monoclonal / therapeutic use
  • Antibodies, Monoclonal, Humanized
  • Bevacizumab
  • Diarrhea / complications
  • Fatal Outcome
  • Fatigue / complications
  • Female
  • Humans
  • Hyperpigmentation / etiology
  • Indomethacin / therapeutic use
  • Neuropeptides*
  • POEMS Syndrome / complications*
  • POEMS Syndrome / drug therapy
  • POEMS Syndrome / physiopathology*
  • Paroxysmal Hemicrania / drug therapy
  • Paroxysmal Hemicrania / etiology*
  • Paroxysmal Hemicrania / physiopathology
  • Prednisolone / therapeutic use
  • Vascular Endothelial Growth Factor A / blood*
  • Vision Disorders / etiology

Substances

  • Angiogenesis Inhibitors
  • Anti-Inflammatory Agents
  • Anti-Inflammatory Agents, Non-Steroidal
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Neuropeptides
  • Vascular Endothelial Growth Factor A
  • Bevacizumab
  • Prednisolone
  • Indomethacin